The role of radiation in liver cancer

Clinical Advances in Hematology and Oncology

Volumn 4, Issue 2, 2006, Pages 113-115

  Lawrence, Theodore S ^a   Pan, Charlie ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; FLOXURIDINE;

BILE DUCT CANCER; CANCER RADIOTHERAPY; CANCER SIZE; CHEMOEMBOLIZATION; COLORECTAL CANCER; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CRYOTHERAPY; DOSIMETRY; GASTROINTESTINAL HEMORRHAGE; HEPATOBILIARY SYSTEM CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIVER CANCER; LIVER INJURY; LIVER METASTASIS; MULTIMODALITY CANCER THERAPY; NOTE; PATIENT SELECTION; RADIATION BEAM; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; RADIOFREQUENCY ABLATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

HUMANS; LIVER NEOPLASMS; RADIOTHERAPY;

EID: 33645334201     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Ben-Josef E, Normolle D, Ensminger WD, et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2005;23:8739-8747.
2. Ben-Josef E, Lawrence TS. Radiotherapy for unresectable hepatic malignancies. Semin Radiat Oncol. 2005;15:273-278.
3. Dawson LA, Lawrence TS. The role of radiotherapy in the treatment of liver metastases. Cancer J. 2004;10:139-144.
4. Dawson LA, McGinn CJ, Lawrence TS. Conformal chemoradiation for primary and metastatic liver malignancies. Semin Surg Oncol. 2003;21:249-255.
5. Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol. 2001;19:164-170.